CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 15 No. 10
Pages: 1  2  3  4  
Next
 

Prevalence of Complementary and Alternative Medicine Use in Cancer Patients

By Bridget J. Bernstein, PharmD
Assistant Professor, Department of Pharmacy Practice, Nova Southeastern University College of Pharmacy, Fort Lauderdale, Florida, and Oncology Pharmacy Specialist, Memorial Regional Hospital, Hollywood, Florida
Teresita Grasso, PharmD

Clinical Pharmacist, Mercy Hospital, Miami, Florida | October 1, 2001
Interest in complementary and alternative medicine (CAM) has grown dramatically over the past several years. Cancer patients are always looking for new hope, and many have turned to nontraditional means. This study was conducted to determine the prevalence of complementary and alternative medicine use in cancer patients and what if any agents are being used. Approximately, 100 adult cancer patients in a private nonprofit South Florida hospital completed a descriptive cross-sectional survey questionnaire. The mean age of participants was 59 years; 42 patients were male and 58, female. According to survey results, 80% of patients reported using some type of CAM; 81% took vitamins, 54% took herbal products, 30% used relaxation techniques, 20% received massages, and 10% used home remedies. Among patients who took vitamins, 65% said they took a multivitamin, 39% took vitamin C, and 31%, vitamin E. The most common herbal remedies used were green tea, Echinacea, shark cartilage, grape seed extract, and milk thistle. Meditation and deep breathing were the two most common relaxation techniques practiced. A large majority of cancer patients are using CAM. In light of the growing interest in CAM, health-care professionals need to be educated about the most common therapies used. [ONCOLOGY 15:1267-1283, 2001]

The use of complementary and alternative medicine (CAM) has grown dramatically over the past 10 years. Alternative medicine refers to treatment options used in place of conventional medicine, whereas complementary medicine refers to therapies used in conjunction with, but not instead of, conventional medicine.[1] In 1990, Eisenberg and colleagues conducted a survey of the prevalence of unconventional therapy use in the United States.[1] The investigators found that 34% of respondents used at least one type of unconventional therapy in the past year. The majority used CAM to treat chronic rather than life-threatening conditions.

Because of the growing popularity of these therapies, the National Institutes of Health (NIH) established the Office of Alternative Medicine (OAM) in 1992.[2] The OAM became the National Center for Complementary and Alternative Medicine (NCCAM) through a congressional mandate in 1998. The primary purpose of the NCCAM is to conduct and support basic and applied clinical research and research training on CAM. Two of its main focuses are to evaluate the safety and efficacy of widely used natural products and to support pharmacologic studies evaluating drug interactions.

When still designated as the OAM, this office classified alternative medicine into seven categories: (1) diet and nutrition, (2) mind-body techniques, (3) bioelectromagnetics, (4) alternative systems of medical practice (traditional and folk remedies), (5) pharmacologic and biological treatments, (6) manual healing methods, and (7) herbal medicine.[3] Overall, the NIH defines "alternative medicine" as therapies that are unproved.[4]

Today, CAM is used primarily to provide symptomatic relief or as preventive therapy for common disease states including arthritis, cardiovascular conditions (hypertension, hyperlipidemia), and illnesses that might be avoided or alleviated through enhancement of the immune system (coughs, colds).[5] A more recent study by Eisenberg and colleagues showed that the use of alternative medicine in the United States has risen to 42% as of 1997.[6] Independent variables that have contributed to the rapid growth of CAM use include distrust of and/or dissatisfaction with conventional medical care, a desire for control over health matters, a holistic health philosophy, chronic health problems, and overall poor health status.[7]

CAM and Cancer

The use of CAM among cancer patients is also rapidly expanding. In this patient population, CAM is generally used to minimize the side effects of or serve as an alternative to conventional chemotherapy.[3] A recent review of 26 surveys showed that the prevalence of CAM use among cancer patients ranged from 7% to 64%.[8] This wide range may be attributed to differences in the definitions of CAM used by each group of investigators and/or differences in patient populations specific to the study site.

Currently, there is much concern about this trend because CAM is often perceived as "natural" and, therefore, harmless.[9] However, it is important to remember that some conventional medicines are derived from plants and are among the more toxic medicines available today. Examples include digoxin(Drug information on digoxin) (foxglove) and vinca alkaloids (Madagascar periwinkle). Among the most common types of CAM being used, herbal therapies can interact with conventional medicines and various disease states or organ systems, leading to significant morbidity.

Besides the potential harm associated with the use of CAM, another major concern is the avoidance or abandonment of conventional therapy and its implications. This is most important in cancer patients who are diagnosed early and have a limited window of opportunity in which to benefit from conventional therapy.[10]

Pages: 1  2  3  4  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy